Related Experiment Video
Updated: Aug 21, 2026

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
Flavopiridol, an inhibitor of transcription: implications, problems and solutions
1Brander Cancer Research Institute, New York Medical College, New York 10532, USA. m_blagosklonny@nymc.edu
Abstract:
After a decade of exciting promises, the CDK inhibitor flavopiridol has quietly failed in most clinical trials. This review discusses that flavopiridol is a potent inhibitor of global transcription. This explains not only downregulation of numerous proteins, cell cycle arrest and apoptosis but also all pleiotropic and mysterious effects of flavopiridol. Yet, flavopiridol is not just a second actinomycin D. As an inhibitor of transcription with a unique mechanism of action, flavopiridol may have tremendous clinical potentials. This article reviews the molecular and cellular effects of flavopiridol as well as mechanisms of therapeutic and side effects, suggesting its novel clinical applications as a single agent and in drug combinations.
Insights
Flavopiridol, a cyclin-dependent kinase (CDK) inhibitor, shows potential as a transcription inhibitor despite clinical trial setbacks. Its unique mechanism offers new therapeutic possibilities for various conditions.
Area of Science:
- Pharmacology
- Molecular Biology
- Oncology
Background:
- Flavopiridol, a cyclin-dependent kinase (CDK) inhibitor, initially showed promise but faced challenges in clinical trials.
- Its complex effects, including protein downregulation, cell cycle arrest, and apoptosis, were not fully understood.
Purpose of the Study:
- To review the molecular and cellular effects of flavopiridol.
- To elucidate the mechanisms behind its therapeutic and side effects.
- To explore novel clinical applications of flavopiridol as a single agent and in combination therapies.
Main Methods:
- Literature review of flavopiridol's effects on global transcription.
- Analysis of molecular and cellular mechanisms of action.
- Evaluation of clinical trial data and preclinical studies.
Main Results:
- Flavopiridol is a potent inhibitor of global transcription, explaining its diverse cellular effects.
- Its unique mechanism distinguishes it from other transcription inhibitors like actinomycin D.
- The drug's pleiotropic effects are linked to its broad impact on gene expression.
Conclusions:
- Flavopiridol's potent transcription inhibition offers significant clinical potential.
- Understanding its mechanisms can guide novel therapeutic strategies, including combination treatments.
- Further research into flavopiridol's unique properties may unlock its full therapeutic value.
More Related Videos
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Bacterial Protein Synthesis
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...

